dc.contributor.author
Mehrhof, Felix
dc.contributor.author
Bergengruen, Paula
dc.contributor.author
Gerds-Li, Jin-Hong
dc.contributor.author
Jahn, Andrea
dc.contributor.author
Kluge, Anne Kathrin
dc.contributor.author
Parwani, Abdul
dc.contributor.author
Zips, Daniel
dc.contributor.author
Boldt, Leif-Hendrik
dc.contributor.author
Schönrath, Felix
dc.date.accessioned
2025-10-22T10:00:34Z
dc.date.available
2025-10-22T10:00:34Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/49926
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-49651
dc.description.abstract
Purpose: Cardiac radioablation (cRA) using a stereotactic single-session radioablative approach has recently been described as a possible treatment option for patients with otherwise untreatable recurrent ventricular tachycardia (VT). There is very limited experience in cRA for patients undergoing left ventricular assist device (LVAD) therapy. We present clinical experiences of two patients treated with cRA for incessant VT under long-term LVAD therapy.Methods: Two male patients (54 and 61 years old) with terminal heart failure under LVAD therapy (both patients for 8 years) showed incessant VT despite extensive antiarrhythmic drug therapy and repeated catheter ablation. cRA with a single dose of 25 Gy was applied as a last resort strategy under compassionate use in both patients following an electroanatomical mapping procedure.Results: Both patients displayed ongoing VT during and after the cRA procedure. Repeated attempts at post-procedural rhythm conversion failed in both patients; however, one patient was hemodynamically stabilized and could be discharged home for several months before falling prey to a fatal bleeding complication. The second patient initially stabilized for a few days following cRA before renewed acceleration of running VT required bilateral ablation of the stellate ganglion; the patient died 50 days later. No immediate side effects of cRA were detected in either patient.Conclusion: cRA might serve as a last resort strategy for patients with terminal heart failure undergoing LVAD therapy and displaying incessant VT. Intermediate- and long-term outcomes of these seriously ill patients often remain poor; therefore, best supportive care strategies should also be evaluated as long as no clear beneficial effects of cRA procedures can be shown. For patients treated with cRA under running ventricular rhythm abnormality, strategies for post-procedural generation of stabilized rhythm have to be established.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
cardiac sbrt
en
dc.subject
heart rhythm
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Cardiac radioablation of incessant ventricular tachycardia in patients with terminal heart failure under permanent left ventricular assist device therapy—description of two cases
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s00066-023-02045-1
dcterms.bibliographicCitation.journaltitle
Strahlentherapie und Onkologie
dcterms.bibliographicCitation.number
5
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
511
dcterms.bibliographicCitation.pageend
519
dcterms.bibliographicCitation.volume
199
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
36750509
dcterms.isPartOf.issn
0179-7158
dcterms.isPartOf.eissn
1439-099X